Skip to main content

Zydelig Side Effects

Generic name: idelalisib

Medically reviewed by Philip Thornton, DipPharm. Last updated on Apr 20, 2023.

Note: This document contains side effect information about idelalisib. Some dosage forms listed on this page may not apply to the brand name Zydelig.

Applies to idelalisib: oral tablet.

Warning

Oral route (Tablet)

Serious hepatotoxicity, including fatalities, has been reported in 16% of patients administered idelalisib. Fatal and/or serious diarrhea and colitis has also been reported in 20% of idelalisib patients. Monitor hepatic function before and during treatment and monitor for the development of diarrhea or colitis. Fatal and/or serious pneumonitis occurred in 4% of idelalisib patients. Monitor for pulmonary symptoms and bilateral interstitial infiltrates. Serious infections, including fatalities, have been reported in 48% of idelalisib patients. Monitor for signs and symptoms of infection. Fatal and serious intestinal perforation may occur. Interrupt, reduce dose, or discontinue treatment with idelalisib as recommended. Discontinue use if intestinal perforation occurs.

Serious side effects of Zydelig

Along with its needed effects, idelalisib (the active ingredient contained in Zydelig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking idelalisib:

More common

Less common

Incidence not known

Other side effects of Zydelig

Some side effects of idelalisib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to idelalisib: oral tablet.

General

The most commonly occurring adverse reactions were pneumonia, pyrexia, sepsis, febrile neutropenia, cough, abdominal pain, chills, rash, fatigue, and diarrhea.[Ref]

Hepatic

Very common (10% or more): Increased ALT (up to 50%), increased AST (up to 41%), increased GGT (up to 26%)[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (up to 47%), nausea (up to 29%), abdominal pain (up to 26%), vomiting (up to 15%)

Common (1% to 10%): Gastroesophageal reflux disease, stomatitis[Ref]

Respiratory

Very common (10% or more): Cough (up to 29%), pneumonia (up to 25%), dyspnea (up to 17%), upper respiratory tract infection (up to 12%)

Common (1% to 10%): Nasal congestion[Ref]

Hematologic

Very common (10% or more): Decreased neutrophils (up to 60%), decreased hemoglobin (up to 28%), decreased platelets (up to 26%), increased lymphocytes (up to 25%), decreased lymphocytes (up to 20%)[Ref]

Metabolic

Very common (10% or more): Hypertriglyceridemia (up to 56%), hyperglycemia (up to 54%), hyponatremia (up to 20%), decreased appetite (up to 16%), hypoglycemia (up to 11%)[Ref]

Other

Very common (10% or more): Pyrexia (up to 35%), fatigue (up to 30%), chills (up to 21%), asthenia (up to 12%), peripheral edema (up to 10%)

Common (1% to 10%): Pain[Ref]

Immunologic

Common (1% to 10%): Sepsis, bronchitis, sinusitis, urinary tract infection[Ref]

Dermatologic

Very common (10% or more): Rash (up to 21%), night sweats (up to 12%)[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia[Ref]

Nervous system

Very common (10% or more): Headache (up to 11%)[Ref]

Psychiatric

Very common (10% or more): Insomnia (up to 12%)[Ref]

Frequently asked questions

References

1. Product Information. Zydelig (idelalisib). Gilead Sciences. 2014.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.